A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 524,947 shares of EBS stock, worth $4.66 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
524,947
Previous 173,747 202.13%
Holding current value
$4.66 Million
Previous $1.18 Million 270.19%
% of portfolio
0.01%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$5.72 - $14.77 $2.01 Million - $5.19 Million
351,200 Added 202.13%
524,947 $4.38 Million
Q2 2024

Aug 09, 2024

SELL
$1.86 - $6.98 $1.33 Million - $5.01 Million
-717,553 Reduced 80.51%
173,747 $1.18 Million
Q1 2024

May 13, 2024

BUY
$1.5 - $3.41 $516,000 - $1.17 Million
344,000 Added 62.85%
891,300 $2.26 Million
Q4 2023

Feb 13, 2024

BUY
$1.82 - $3.16 $996,086 - $1.73 Million
547,300 New
547,300 $1.31 Million
Q4 2022

Feb 13, 2023

BUY
$11.0 - $21.45 $2.74 Million - $5.34 Million
248,900 Added 451.72%
304,000 $3.59 Million
Q3 2022

Nov 14, 2022

SELL
$20.09 - $35.8 $801,591 - $1.43 Million
-39,900 Reduced 42.0%
55,100 $1.16 Million
Q2 2022

Aug 12, 2022

SELL
$27.42 - $43.63 $7.21 Million - $11.5 Million
-263,000 Reduced 73.46%
95,000 $2.95 Million
Q1 2022

May 13, 2022

BUY
$36.48 - $52.22 $13.1 Million - $18.7 Million
358,000 New
358,000 $14.7 Million
Q1 2021

May 13, 2021

SELL
$86.23 - $125.19 $5.35 Million - $7.77 Million
-62,100 Closed
0 $0
Q4 2020

Feb 10, 2021

BUY
$79.17 - $111.47 $1.42 Million - $2.01 Million
17,996 Added 40.8%
62,100 $5.56 Million
Q3 2020

Nov 13, 2020

SELL
$81.91 - $134.94 $27.9 Million - $45.9 Million
-340,520 Reduced 88.53%
44,104 $4.56 Million
Q2 2020

Aug 13, 2020

SELL
$54.33 - $89.52 $13 Million - $21.3 Million
-238,377 Reduced 38.26%
384,624 $30.4 Million
Q1 2020

May 14, 2020

SELL
$49.34 - $68.76 $6.96 Million - $9.7 Million
-141,100 Reduced 18.47%
623,001 $36 Million
Q4 2019

Feb 13, 2020

SELL
$51.21 - $59.06 $11.3 Million - $13 Million
-220,210 Reduced 22.37%
764,101 $41.2 Million
Q3 2019

Nov 13, 2019

SELL
$40.6 - $57.2 $14.9 Million - $20.9 Million
-366,200 Reduced 27.12%
984,311 $51.5 Million
Q2 2019

Aug 12, 2019

SELL
$39.92 - $53.86 $25.1 Million - $33.8 Million
-627,891 Reduced 31.74%
1,350,511 $65.2 Million
Q1 2019

May 14, 2019

BUY
$48.23 - $66.16 $18.4 Million - $25.3 Million
382,391 Added 23.96%
1,978,402 $99.9 Million
Q4 2018

Feb 13, 2019

BUY
$55.63 - $73.24 $88.8 Million - $117 Million
1,596,011 New
1,596,011 $94.6 Million

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $442M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.